In This Section      
Print This Page

Clinical Trials

Currently Enrolling Research Studies in Movement Disorders

Your participation will allow you to have firsthand experience with developing new medical treatments that may be beneficial to others. Current treatment methods for neurologic disorders are only available because of volunteer participants in clinical trials. Clinical trial information is excerpted from www.clinicaltrials.gov.

Parkinson's Disease and Related Disorders

Parkinson's Progression Markers Initiative: Genetic Cohort (NA_00039232)

Objective: Identify links to PD and learn how the LRRK2 mutation affects certain populations (Part of the Michael J. Fox Foundation Parkinson's Progression Markers Initiative)
Eligibility: 1. Individuals diagnosed with PD who are of Ashkenazi Jewish descent and have a first-degree relative with PD
P.I.: Liana Rosenthal, M.D. Contact: Kori Ribb: 410-614-2216

APL-130277 for the Acute Treatment of OFF Episodes (NA_00086593)

Objective: Evaluate APL-130277 (sublingual version of apomorphine hydrochloride) in treatment of sudden "off time" in PD
Eligibility: Individuals with PD taking levodopa and having at least 2 hours of "off time" daily
P.I.: George Ricaurte, M.D. Contact: Kori Ribb: 443-287-7850

Anxiety in Parkinson's (NA_00092051)

Objective: One day visit to assess anxiety symptoms in PD
Eligibility: All individuals diagnosed with PD
P.I.: Gregory Pontone, M.D. Contact: Kate Perepezko: 410-614-1242

Rotigotine for Anxiety in Parkinson's (NA_00092051)

Objective: Eight-week study of rotigotine for the treatment of anxiety disorders in PD
Eligibility: Individuals diagnosed with PD experiencing anxiety
P.I.: Gregory Pontone, M.D. Contact: Kate Perepezko: 410-614-1242

Udall Center Longitudinal Study (NA_00032761)

Objective: Examine the relationship between the clinical symptoms of PD and the disease process in brain tissue. Participation involves eventual brain donation.
Eligibility: Individuals diagnosed with PD or atypical PD and those without a neurological diagnosis
P.I.: Liana Rosenthal, M.D. Contact: Catherine Bakker: 410-616-2814

Udall Center Brain Donation Program (NA_00032761)

Objective: Examine the pathological changes in the brain tissue of individuals diagnosed with PD or related disorders as compared to controls
Eligibility: Individuals diagnosed with PD or atypical PD and those without a neurological diagnosis
P.I.: Liana Rosenthal, M.D. Contact: Catherine Bakker: 410-616-2814

Establishment of a Clinical Neuropsychological Database on Parkinson's Disease and Other Movement Disorders (NA_0001573)

Objective: To assemble cognitive, mood and other psychological test results for use in future studies
Eligibility: All PD and ET patients seen for clinical assessment in the Division of Medical Psychology
P.I.: Jason Brandt, Ph.D. Contact: Barnett Shpritz: 410-955-1469

Effects of Subthalamic Nucleus Deep Brain Stimulation on Decision Making in Parkinson's Disease (IRB 00078439)

Objective: To determine whether treatment with DBS changes the perceived value of prizes and rewards, attitudes toward risk taking and other aspects of decision making
Eligibility: All PD and ET patients seen for clinical assessment in the Division of Medical Psychology
P.I.: Jason Brandt, Ph.D. Contact: Barnett Shpritz: 410-955-1469

National Parkinson Foundation Patient Registry (NA_0036863)

Objective: Develop quality care standards for PD
Eligibility: All PD patients and care partners seen at the center
P.I.: Kelly Mills, M.D. Contact: Nikki Mennucci: 410-955-6684

Exploring Mechanisms for Neuropsychiatric Symptoms of PD Using Transcranial Direct Current Stimulation (tDCS) (NA_008795)

Objective: To study if tDCS helps depression, cognition or other non-motor PD symptoms
Eligibility: All individuals diagnosed with PD who have symptoms of depression
P.I.: Kelly Mills, M.D. Contact: Yousef Salimpour: 410-502-2666

Investigations of Neurovascular Abnormalities in the Olfactory Cortex Using Advanced MRI Technologies (IRB00141396)

Objective: To investigate neurovascular abnormalities in the olfactory cortex using advanced MRI techniques
Eligibility: PD patients diagnosed for more than 3 years who are able to tolerate an MRI brain scan and undergo smell and memory identification tasks
P.I.: Jun Hua, Ph.D. Contact: Adrian Paez: 443-923-9551

 

Other Movement Disorders

General Characterization: Movement Disorders (NA_000554)

Objective: To study the genetic risk factors involved in movement disorders
Eligibility: Individuals with PD, atypical parkinsonism, dystonia, ataxia and Lewy body dementia
P.I.: Jeffrey Rothstein, M.D., Ph.D. Contact: Kecia Garrett: 410-502-0133

Progressive Supranuclear Palsy: PASSPORT (IRB00127218)

Objective: To determine if an investigational medication (BMS 986168) may potentially treat human tauopathies such as progressive supranuclear palsy (PSP)
Eligibility: Individuals diagnosed with PSP (possible or probable) < 5 years
P.I.: Alex Pantelyat, M.D. Contact: Emily Carman: 410-955-8909

4RTNI-2 (NA_00130505)

Objective and Eligibility: Select individuals with CBD, PSP or vPSP; healthy controls, caregiver component
P.I.: Alex Pantelyat, M.D. Contact: Diane Lanham: 443-287-4156

Request an Appointment

Maryland Patients

To request an appointment, please contact the Johns Hopkins Parkinson’s Disease and Movement Disorders Center at 410-502-0133.
Request an Appointment

Adult Neurology: 410-955-9441
Pediatric Neurology: 410-955-4259
Adult Neurosurgery: 410-955-6406
Pediatric Neurosurgery: 410-955-7337

 

Traveling for Care?

Whether you're crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

Outside of Maryland (toll free)
410-464-6713

Request an Appointment
Medical Concierge Services

International Patients
+1-410-502-7683

Request an Appointment
Medical Concierge Services

 
blue suitcase